MXI1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.614400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.231600E-01
Normal-vs-Stage2
6.110000E-01
Normal-vs-Stage3
9.054800E-01
Normal-vs-Stage4
6.064800E-01
Stage1-vs-Stage2
8.229200E-01
Stage1-vs-Stage3
5.854200E-01
Stage1-vs-Stage4
7.784000E-01
Stage2-vs-Stage3
4.684600E-01
Stage2-vs-Stage4
9.028400E-01
Stage3-vs-Stage4
4.770400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.834400E-01
Normal-vs-AfricanAmerican
7.419600E-01
Normal-vs-Asian
6.418400E-01
Caucasian-vs-AfricanAmerican
9.373000E-01
Caucasian-vs-Asian
6.586400E-01
AfricanAmerican-vs-Asian
8.683800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.339200E-01
Normal-vs-Female
7.015400E-01
Male-vs-Female
7.639600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.405200E-01
Normal-vs-Age(41-60Yrs)
3.536200E-01
Normal-vs-Age(61-80Yrs)
8.197400E-01
Normal-vs-Age(81-100Yrs)
8.827000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.462560E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.371000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.868800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.079780E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.410980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.785800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.660400E-01
Normal-vs-Daily Drinker
6.130000E-01
Normal-vs-Weekly Drinker
9.771600E-01
Normal-vs-Occasional Drinker
4.322400E-01
Normal-vs-Social Drinker
6.427000E-01
Non Drinker-vs-Daily Drinker
5.803600E-01
Non Drinker-vs-Weekly Drinker
6.124600E-01
Non Drinker-vs-Occasional Drinker
2.790800E-01
Non Drinker-vs-Social Drinker
5.438000E-01
Daily Drinker-vs-Weekly Drinker
3.679400E-01
Daily Drinker-vs-Occasional Drinker
6.267200E-01
Daily Drinker-vs-Social Drinker
8.880000E-01
Weekly Drinker-vs-Occasional Drinker
1.741750E-01
Weekly Drinker-vs-Social Drinker
3.956000E-01
Occasional Drinker-vs-Social Drinker
7.985000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.712200E-02
Normal-vs-Grade 2
5.075400E-03
Normal-vs-Grade 3
7.982400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.760240E-02
Grade 1-vs-Grade 3
4.132000E-02
Grade 1-vs-Grade 4
6.712200E-02
Grade 2-vs-Grade 3
9.856000E-01
Grade 2-vs-Grade 4
5.075400E-03
Grade 3-vs-Grade 4
7.982400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.030200E-01
Normal-vs-NonDiabetic
6.576200E-01
Diabetic-vs-NonDiabetic
5.651000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.911600E-01
Normal-vs-NoPancreatitis
7.073800E-01
Pancreatitis-vs-NoPancreatitis
9.901600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.352800E-01
Normal-vs-N1
6.045800E-01
N0-vs-N1
2.415800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.437000E-01
Normal-vs-TP53-NonMutant
9.487800E-01
TP53-Mutant-vs-TP53-NonMutant
1.118250E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
